Interleukin-l1 (IL-11
ulocyte / erythrocyte / macrophage / megakaryocyte (CFU -GEMM) formation from day-2 post 5-fluorouracil (5-FU) marrow cells in vitro.'.' These effects of IL-l I on both murine and human stem andor primitive progenitors may be due to the entry of dormant stem cells into the cell cycle.y However, IL-11 administration in vivo has little effect on day 12 colony forming unit-spleen (CFU-S) content in either the bone marrow (BM) or spleen of BM transplant (BMT) recipient mice." 1L-1 1 significantly increases peripheral total leukocyte (especially neutrophil) and platelet counts, as well as total cellularity and the content of multilineage progenitor cells in BM and spleen of treated animals." These data suggest that increases in primitive cell numbers seen in vitro cultures with recombinant cytokines may not reflect hematopoietic microenvironment (HM)/hematopoietic stem cell interactions occurring in vivo.
To more accurately determine the effects of IL-l1 on different hematopoietic cell compartments within the HM, we added recombinant human IL-1 I to human and murine long-term bone marrow cultures (LTMC) and analyzed stem and progenitor compartments for an extended period. We report that IL-I l significantly stimulates myeloid hematopoiesis, including myeloid and multipotential progenitors i n both human and murine LTMC; however, IL-I I does not significantly increase the number of high proliferative potential-colony forming cells (HPP-CFC) in murine LTMC and appears to decrease the size of the most primitive stem cell compartment in both human and murine LTMC. Taken together with previous studies, these data suggest a role of IL-1 I in commitment of primitive hematopoietic stem cells. with 10% fetal calf serum (FCS; GIBCO, Grand Island, NY), 100 U/mL penicillin, and 1 0 0 pg/mL streptomycin (GIBCO). Human BM cells were layered on Ficoil-Paque (Pharmacia, Piscataway, NJ) and subjected to centrifugation at 1,500 rpm for 30 minutes at room temperature. Cells at the interface were collected and washed twice with IMDM and then counted on a Coulter Counter (Model ZM; Coulter Electronics, Hialeah, FL) with a 100-pm aperture, after the addition of Zapoglobin (Coulter) for red blood cells lysis (according to the manufacturer's recommendations). Ten million (IO') low density mononuclear cells were seeded into 25-cm2 cell culture flasks (Costar, Cambridge, MA) in human LTMC media containing IMDM supplemented with 10% horse serum (GIBCO), 10% FCS (GIBCO), mol& hydrocortisone sodium succinate (Solu-Cortef; Upjohn, Kalamazoo, MI), 350 pglmL sodium chloride (Sigma, St Louis, MO), 100 U/mL penicillin, and 100 pg/mL streptomycin.
MATERIALS AND METHODS

Mice
Murine bone marrow cells from C57B1/6J mice sacrificed by cervical dislocation were flushed from femurs and tibias using murine LTMC media containing Fischer media (GIBCO) supplemented with 20% horse serum (GIBCO), m o m hydrocortisone sodium succinate (as above), 1 pg/mL sodium bicarbonate, mol& 2-mercaptoethanol (BME, Sigma), 100 U/mL penicillin, and 100 pg/ mL streptomycin. A single cell suspension was obtained by passing the bone marrow cell suspension through a 25-gauge needle several times. Murine BM cells were washed and counted as above. Ten million (lo') murine BM cells were seeded into 25-cm2 cell culture flasks (as above). Both human and murine cultures were maintained at 33T, 5% CO2 and humidified atmosphere. Recombinant human (rh) IL-l1 (Genetics Institute, Cambridge, MA) was added twice weekly at a final concentration of 100 ng/mL. Human and murine LTMC were fed following 70% and 50% depopulation, respectively, weekly.
Human colony-forming units-megakaryocyte (CFU-Mk) assay. All nonadherent (NA) cells from weekly feedings of human cultures were pooled and subsequently plated in the presence of rhIL-3 (Genzyme, Boston, MA) (10 ng/mL) and rh stem cell factor (SCF) (Amgen. Thousand Oaks, CA) (100 ng/mL) in a single serum-depleted, fibrin clot culture system at a cell density of 2 X IO5 cells/mL as previously described." Briefly, an IMDM-based serum substitute solution consisting of iron-saturated human transfemn (Sigma) (90 pg/mL), sodium bicarbonate (0.04%, wt/vol, GIBCO), bovine serum albumin (0.09%, wt/vol, BSA, Fraction V, Calbiochem, La Jolla, CA), L-asparagine mol& GIBCO), calcium chloride (CaCI2) (280 pglmL), and 55 mmom c-amino-n-caproic acid (Sigma) were used. A semisolid clot matrix was achieved from the interaction of fibrinogen (0.3%, wt/vol, Kabi, Stockholm, Sweden) and 0.3 pg/mL thrombin (Sigma) diluted in phosphate-buffered saline (PBS). A final volume of 1 mL was plated per 35-mm gridded tissue culture dish (Costar) and incubated for 12 to 14 days at 3 7 T , 5% CO2 in an humidified atmosphere. After incubation, fibrin clots were fixed in situ in methanokacetone (1:3) for 20 minutes, washed with PBS, and air dried. The fixed dishes were stained with IOE5, a murine monoclonal antibody against human platelet glycoprotein (gp)IIbIIIa receptor complex (provided by Dr Bany S. Coller, Mt Sinai, New York) at a dilution of 1:400 in PBS for 1 hour at 4°C with gentle agitation. After washing in PBS, fluorescein isothiocyanate (FITOconjugated goat antimouse polyclonal antibody (Kirkegaard & Perry, Gaithersburg, MD) was added at a dilution of 1:20 for 1 hour at 4°C. After washing with PBS, nonmegakaryocyte colonies were counter-stained using a 0.125% Evans Blue (Sigma) for 1.5 minutes at room temperature. Subsequently the 35-mm petri dishes were inverted, and the base area was completely scored at lOOX using a fluorescence microscope (Axioskop, Zeiss) equipped with a band pass excitation filter at 450 to 490 nm (Zeiss). A CFUMk-derived colony was defined as a cluster of three or more RTCpositive cells (assayed in duplicates). The results are expressed as cumulative means of observable CFU-Mk-derived colonies determined weekly from two separate experiments. This represents the total number of CFU-Mk produced by the cultures during the time noted in the figure legend.
Myeloid progenitor assays. NA cells obtained weekly from LTMC were centrifuged and washed; the cell pellet was resuspended in IMDM (human) or a-MEM (murine) and counted as described above. Human NA cells (4 X IO4 cells) were plated in I-mL aliquots of 1.1 % methylcellulose (Fluka, Hauppauge, NY) in IMDM supplemented with 26% FCS (GIBCO), 10% human plasma (obtained from individual volunteers), IO-' mol/L 2-mercaptoethanol (BME; Sigma), 4U erythropoietin (Epo; Amgen), 10 ng recombinant human IL-3 (Genzyme), 100 ng rhSCF, 100 U penicillin and 100 pg streptomycin (GIBCO). A total of 2 X IO4 murine NA cells were plated in I-mL aliquots of 1% methylcellulose (Fluka) in a-MEM supplemented with 30% FCS, mol/L BME (Sigma), 2 mmol/L glutamine (GIBCO), 4 U Epo (Amgen), 20 U recombinant murine IL-3 (Genzyme), 100 ng recombinant rat (TT) SCF (Amgen), penicillin and streptomycin (as above). Triplicate or quadruplicate cultures were incubated at 37°C in 5% CO, in humidified 10 X 35-mm tissue culture dishes (Nunc Inc, Naperville, IL) for 12 to 14 days and colonies (>50 cells) were counted on an inverted microscope and scored as colony-forming units granulocyte and macrophage (CFU-GM), burst-forming units-erythroid (BFU-E), or multilineage colony-forming units (CFU-Mix).
Day 12 CFU-S assay. Donor cells from murine LTMC were injected via tail vein into lethally irradiated C57B116J recipient mice ( I 1 Gy, 96 cGy/min in two doses divided by at least 4 hours, using a '"CS irradiator, Nordion, Kanata, Canada). A minimum of five mice were used as recipients per time point per experiment. Twelve days after marrow infusion, the recipients were sacrificed by cervical dislocation, spleens were removed and fixed in Telly's fixative (70% ethano1:acetic acid:fonnalin at 20:1:1), and the macroscopic surface colonies present in each spleen were counted using a dissecting microscope.
HPP-CFC assay. Double-layer agar cultures were prepared as described."." Recombinant hematopoietic growth factors including 100 ng rrSCF (Amgen), 1,600 U human macrophage colony-stimulating factor (M-CSF, Genetics Institute), 200 U murine IL-3 and 1,000 U murine IL-la (Genzyme) were added to each 10 X 35-mm gridded tissue culture dish. The underlayer contained 1 mL O-MEM media with 0.5% agar, 2 mmom glutamine, 0.224% (wt/vol) sodium bicarbonate, 20% FCS, penicillin, and streptomycin (as above). Triplicate cultures of 5 X lo4 nonadherent or adherent cells from murine LTMC were plated in 0.5 mL a-MEM media (containing 0.33% agar, glutamine, sodium bicarbonate, FCS, penicillin, and streptomycin as in the underlayer) per dish with above cytokines and incubated in 5% 02, 10% CO2 in humidified atmosphere. After 14 days incubation, the dense compact macroscopic colonies greater than 0.5 mm were scored as HPP-CFC.
Long-term repopularion assay. Ali cells from 4-week-old murine LTMC established with bone marrow from C57B1/6J mice (homozygous for single hemoglobin, HbbYHbb') were intravenously injected to WBB6FI-WW mice (heterozygous for diffuse and single hemoglobin, Hbbd/HbW), at cell dilutions of 0.5 flaskhouse, 1 flaskhouse and 2 flaskdmouse, respectively. The presence of single hemoglobin and disappearance of diffuse hemoglobin were examined monthly posttransplantation as described?" The presence of single hemoglobin without diffuse hemoglobin in W N ' recipient mice at 4 months posttransplantation was considered evidence of reconstitution by donor stem cells present in LTMC. (Fig 1 A) . In contrast to human LTMC, IL-1 1 added to murine LTMC resulted in more profound and persistent increases in NA cellularity (Fig IB) . IL-I I significantly increased NA cells from weeks 3 through 13 in murine LTMC. IL-1 1 -treated murine cultures showed a 20-fold increase in NA cellularity compared with control cultures at week 7 of LTMC, which was the peak of NA cellularity of IL-1 Itreated cultures. These data are from one of three independent experiments showing similar results. We also examined the effect of IL-l l on the adherent cellularity of murine LTMC. In contrast to the effect on human LTMC," the addition of IL-I 1 was found to decrease the cellularity of adherent cells in murine LTMC, and this decrease only reached significance at weeks 15 and 17 of murine LTMC (data not shown).
RESULTS
Effects
Evaluation of progenitor compartments. Addition of 1L-1 I to human LTMC resulted in a fourfold increase in the cumulative production of CFU-Mk over 6 weeks of culture (Fig 2) . Figure 3 shows the effects of IL-I 1 on myeloid progenitor production in both human and murine LTMC. At weeks 4 and 6 of human LTMC, the addition of JL-l1 increased CFU-GM production by threefold and twofold, respectively, compared with control cultures (Fig 3A) . However, by weeks 10 and 12, IL-l l -treated human LTMC demonstrated significantly lower CFU-GM production ( Fig  3A) . In contrast to these effects in human LTMC, IL-I I resulted in a prolonged and dramatic increase in myeloid progenitor content in murine LTMC (Fig 3B) . IL-l I -treated murine cultures demonstrated significantly higher CFU-GM content than control cultures from week 4 to week 13. By week 7 of murine LTMC, IL-I 1 treatment resulted in more than a @fold increase in CFU-GM content in NA cells Evuluation of less primitive nzultilineuge stenz cell cornpurtments. Addition of IL-I 1 to murine LTMC enhanced the production of day 12 CFU-S in both nonadherent and adherent layers (Table I) . Although there were no significant differences in the number of CFU-Sl2 from the adherent layer at 3 weeks of LTMC, IL-I 1 markedly increased CFU-S I L content in the adherent layer at week 7. However, by weeks 13 and IS of culture, the content of CFU-S,? in the adherent layer of IL-I I -treated cultures became undetectable or much lower than in control cultures ( Table 1) . IL-I I significantly increased CFU-SI2 numbers in the nonadherent cells from week 5 through week 10 (data from weeks 7 and IO shown) of LTMC (Table l) . At week 7 of murine LTMC, IL-1 I -treated cultures demonstrated greater than a 27-fold increase in CFU-S12 compared with control cultures in nonadherent cells. Again, later in the culture period, IL-l ltreated cultures showed diminished CFU-SI2 numbers in the NA cell population compared with control, similar to the effect of IL-l1 on CFU-S,2 in the adherent cells. Table 1 also summarizes the effect of 1L-l1 on total day I2 CFU-S numbers from both nonadherent and adherent cells in murine LTMC. IL-l1 addition increased total CFU-Sf2 at weeks 7 and IO, but decreased CFU-SI2 numbers at weeks 13 and 15. The effect of IL-I 1 on more primitive HPP-CFC numbers was more complicated (Table 2) Table 2 ). The net effect of IL-11 addition to murine LTMC was no significant change in the number of HPP-CFC during the 15 weeks of culture ( Table 2) .
Effects of IL-I 1 on more primitive stem cell compartments. In contrast to the effects of IL-11 on committed and multilineage progenitor compartments in LTMC, IL-11 -treated human LTMC demonstrated a decreased frequency of primitive hematopoietic stem cells compared with control cultures at week 4 and week 8 using limiting-dilution LTC-IC assay ( Table 3) . At week 4 of human LTMC, the frequency of LTC-IC in IL-11 -treated cultures were almost twofold lower than control cultures. At week 8 of culture, LTC-IC in IL-1 I -treated cultures became undetectable, while LTC-IC were still measurable in control cultures. By week 12, no LTC-IC were detected in either control or IL-1 l-treated human LTMC. To more precisely determine the effect of IL-I1 on reconstituting hematopoietic stem cells, we quantitated stem cells present in murine LTMC by an in vivo long-term repopulation assay (Fig 4) . After 4 weeks of IL-11 treatment, the frequency of long-term reconstituting stem cells (assayed 6 months after transplantation) was decreased in murine LTMC compared with control cultures. None of 15 W/W' mice were reconstituted by cells from IL-I 1 -treated cultures at cell doses of 0.5 and 1 flask per mouse, while 50% of W W recipients were reconstituted by infusion of 2 flasks per mouse from IL-11 -treated LTMC. Mice infused with cells from vehicle treated (control) cultures demonstrated dose-dependent engraftment with 17% (one of six mice), 33% (two of six mice), and 75% (three of four) of mice reconstituted by infusion 0.5 flask, 1 flask, and 2 flasks per mouse, respectively (Fig 4) . in vitro.7-9.12.13.25 These data suggest that IL-l1 stimulates a marrow cultures resulted in a significant increase in both cellularity and production of myeloid-restricted progenitor cells, including a consistent increase in the production of megakaryocyte progenitor cells, CFU-Mk. We have previously reported increased cellularity and myeloid progenitor production in human LTMC treated with IL-1 although our previous studies did not examine effects on CFU-Mk. Multilineage progenitors and less primitive stedprogenitor cells, such as CFU-Mix and day 12 CFU-S are also increased in the early phases of LTMC by addition of IL-1 l. Production of these multilineage progenitor cells appear to diminish as the culture period lengthens, perhaps as a result of effects of L 1 1 on the stromal compartment or due to exhaustion of more primitive progenitors. We have not yet examined whether this effect can be modulated by addition of smaller amounts of IL-l 1 in these cultures. Human IL-I1 was detected at high concentrations before feeding in the treated cultures by enzyme-linked immunosorbent assay (ELISA) (X.X. Du and D.A. Williams, unpublished data), demonstrating that exogenous hIL-11 protein was stable in this in vitro culture system. We are currently examining the effects of IL-l1 on the stromal cells in the HM, although our laboratory and other investigators have previously demonstrated potent inhibitory effects of IL-I l on differentiation of adipoMore primitive stem cell compartments were analyzed in murine cultures by long-term reconstitution in vivo and by the use of HPP-CFC cultures in vitro. No quantitative effects were seen on HPP-CFC numbers, although IL-l1 clearly lead to mobilization of HPP-CFC from the adherent compartment to the nonadherent compartment of LTMC. Whether this mobilization from the stromal adherent layer is a similar phenomenon to mobilization of pluripotent progenitor cells from the BM to peripheral blood is unknown. IL-11 has been cytes.21.27.28 A current limitation of experimental analysis of human hematopoietic stem cell populations is the lack of a reconstituting assay system. Several in vitro assays have been developed, which measure primitive human hematopoietic cells, although the exact correlation of the cells scored in these assay systems with the cell responsible for long-term reconstitution in vivo remains unknown.29 Several investigators have hypothesized that the ability of cells to initiate longterm marrow cultures correlates with reconstitution capacity and quantitative analysis of this cell, termed long-term culture-initiating cells, as has been described."."
The chronic exposure of human LTMC to IL-11 appears to diminish the frequency of LTC-IC. Because murine and 
